Literature DB >> 25448128

[Spotted fever and the invention of its serodiagnosis and vaccination in the Austro-Hungarian army in World War I].

Heinz Flamm1.   

Abstract

After description of the medical institutions and epidemiological situations of the Austro-Hungarian army in World War I the provisions against spotted fever focused on louse control are discussed. The letter specified for the army had to be adjusted for the local populations. 1915 in the k.u.k. military service in Galicia Edmund Weil and Arthur Felix cultivated Proteus strains from urine of soldiers with spotted fever. As sera of such patients agglutinated these bacteria in considerable titers the investigators developed the reliable diagnostic "Weil-Felix-Test" used still today. In the same military area and time Rudolf Weigl invented the anal infection of lice. This enabled him to harvest a great amount of louse intestines containing the spotted fever Rickettsiae in their epithelial cells. Lots with defined numbers of intestines were homogenized, sterilized and used with success as vaccine for medical staff. This sort of vaccine still was used in World War II.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25448128     DOI: 10.1007/s10354-014-0332-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  4 in total

1.  The Wilson-Weil-Felix Reaction in Typhus Fever.

Authors:  W J Wilson
Journal:  J Hyg (Lond)       Date:  1920-07

2.  [The Austrian Red Cross and Austrian bacteriologists in the Balkan wars 1912/13 - Centenary of the first application of the bacteriology in theatres of war].

Authors:  Heinz Flamm
Journal:  Wien Med Wochenschr       Date:  2012-04

3.  [Elucidation of pappataci fever by Austrian miliary physicians].

Authors:  Heinz Flamm
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  THE ANTIGENIC RELATIONSHIP BETWEEN PROTEUS X-19 AND TYPHUS RICKETTSIA : II. A STUDY OF THE COMMON ANTIGENIC FACTOR.

Authors:  M R Castaneda
Journal:  J Exp Med       Date:  1934-06-30       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.